Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | ALPL | P05186 | 1/20 | 0.60 |
| ▸ | ALPI | P09923 | 1/20 | 0.60 |
| ▸ | ALPG | P10696 | 1/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | PLEC | Q15149 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 16/20 | 0.58 |
| ▸ | CA1 | P00915 | 14/20 | 0.58 |
| ▸ | CA2 | P00918 | 14/20 | 0.58 |
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12997225 | 0.89 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL2755000 | 0.89 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15369507 | 0.87 | USP2 (0.66) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15369505 | 0.87 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15304973 | 0.87 | USP2 (0.71) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL1437042 | 0.84 | USP2 (0.78) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20254033 | 0.84 | USP2 (0.77) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14013402 | 0.84 | USP2 (0.64) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL19928054 | 0.84 | USP2 (0.64) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL10098714 | 0.84 | USP2 (0.76) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2656410-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2017-07-05 | — | — | EP | disclosed |
| US-20150212068-A1 | Cholyl-L-Lysyl-Fluorescein Assay | NOVASSAY SA (CH) | 2015-07-30 | — | — | US | disclosed |
| US-20130296288-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2013-11-07 | — | — | US | disclosed |
| US-20080139493-A1 | Bi- or Tetra-Guanidino-Biphenyl Compounds as Small Molecule Carriers | UCL BUSINESS PLC (GB) | 2008-06-12 | — | — | US | disclosed |
| US-20070221884-A1 | Liminescent Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-09-27 | — | — | US | disclosed |
| US-7183405-B2 | Compositions and methods for labeling oligonucleotides | SYN GEN, INC. (US) | 2007-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139493-A1 | Bi- or Tetra-Guanidino-Biphenyl Compounds as Small Molecule Carriers | CBR3, CBR1, KCNQ3 | USP2 3328/4885L3MBTL1 2053/4885MEN1 1701/4885 |
| US-20130296288-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SLC26A3, SLCO4C1, ICMT | USP2 4747/4885L3MBTL1 3388/4885MEN1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.